Story excerpt provided by Yahoo Finance.
Centerline Biomedical, Inc. has recently closed on a $1.7M seed investment to advance its cutting-edge vascular navigation system based on the research from Cleveland Clinic’s Heart & Vascular Institute. The funding provides critical resources for the next phase of development and additional testing of Centerline’s proprietary surgical navigation system.
Centerline technology significantly reduces the radiation exposure to patients and caregivers and provides the surgeon with a “GPS-like” tool, making these procedures safer, more accurate, and cost-effective. The platform technology is first aiming to revolutionize the endovascular aneurism repair market, but plans are in place to address a variety of vascular procedures.
Click here to read the complete article.
Originally published August 28, 2015.